Concepedia

Kee‐Sik Kim

KK

Statistics

Publications

37

Citations

6.2K

H-Index

24

Active since

1994

Affiliations

Keimyung University(Current)

Daegu Catholic University Medical Center

Daegu Catholic University

Chonnam National University Hospital

Keimyung University Dongsan Medical Center

Kee‐Sik Kim is an author at Keimyung University specializing in medicine, cardiovascular disease, and cardiology.

ORCID

Top concepts

Publications per year

1994–2023

37

Publications

37

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

Milton Packer, John J.V. McMurray, Akshay S. Desai et al. · Circulation · 2014 · 661 citations · Full text

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress

Jang‐Ho Bae, E. Bassenge, Yoon-Nyun Kim et al. · Atherosclerosis · 2001 · 367 citations · Full text

, , +9

Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

Cheol Whan Lee, Jung‐Min Ahn, Duk‐Woo Park et al. · Circulation · 2013 · 278 citations · Full text

1–5 of 37